


Searching News Database: Orsiro
HSMN NewsFeed - 23 May 2018
Newest Generation of Leading Heart Stent is Now Approved in the U.S. for People with Coronary Artery Disease
Newest Generation of Leading Heart Stent is Now Approved in the U.S. for People with Coronary Artery Disease
HSMN NewsFeed - 28 Aug 2017
ESC Congress 2017: BIOTRONIK's Orsiro Drug-Eluting Stent Outperforms Xience in BIOFLOW-V Trial
ESC Congress 2017: BIOTRONIK's Orsiro Drug-Eluting Stent Outperforms Xience in BIOFLOW-V Trial
HSMN NewsFeed - 21 Aug 2017
BIOTRONIK US Launches Smallest MR Conditional Quadripolar Cardiac Resynchronization Therapy Pacemaker
BIOTRONIK US Launches Smallest MR Conditional Quadripolar Cardiac Resynchronization Therapy Pacemaker
HSMN NewsFeed - 3 Jul 2017
BIOTRONIK US Announces Pivotal Trial Results of the Pulsar-18 Stent with 4-French Delivery System
BIOTRONIK US Announces Pivotal Trial Results of the Pulsar-18 Stent with 4-French Delivery System
HSMN NewsFeed - 18 Apr 2017
BIOTRONIK Introduces Smallest MR Conditional Defibrillator Lead in the US
BIOTRONIK Introduces Smallest MR Conditional Defibrillator Lead in the US
HSMN NewsFeed - 30 May 2013
Orsiro From BIOTRONIK, Industry's First Hybrid Drug-Eluting Stent, Performs as Best in Class
Orsiro From BIOTRONIK, Industry's First Hybrid Drug-Eluting Stent, Performs as Best in Class
